Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Maloney, David G
1512  Ergebnisse:
Personensuche X
?
1

Acalabrutinib in Combination with Anti-CD19 Chimeric Antige..:

Poh, Christina ; Chow, Victor A ; Lynch, Ryan C...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S33 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Characteristics Associated With Response to Lisocabtagene M..:

Wierda, William G. ; Maloney, David G. ; Kenderian, Saad S....
Clinical Lymphoma Myeloma and Leukemia.  24 (2024)  - p. S180 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Lisocabtagene Maraleucel (liso-cel) in Patients (Pt) With R..:

Shah, Nirav N. ; Siddiqi, Tanya ; Maloney, David G....
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S353-S354 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Identification of Predictors of CRS and Neurotoxicity Durat..:

Albittar, Aya ; Voutsinas, Jenna M ; Portuguese, Andrew J....
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S175 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Planned Interim Analysis of a Phase 2 Investigator-Initiate..:

Liang, Emily C. ; Albittar, Aya ; Portuguese, Andrew J....
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S179-S180 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Real-World Comparison of Lisocabtagene Maraleucel (Liso-Cel..:

Portuguese, Andrew J. ; Albittar, Aya ; Huang, Jennifer J....
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S192 , 2024
Link: https://doi.org/10.1016/..
 
?
7

Safety and Efficacy of Fully-Human-Binder-Bearing CD19 CAR ..:

Huang, Jennifer J. ; Hirayama, Alexandre V ; Jaeger-Ruckstuhl, Carla A...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S186 , 2024
Link: https://doi.org/10.1016/..
 
?
8

Detecting HLA loss of heterozygosity within a standard diag..:

Lozac'hmeur, Ariane ; Danek, Tyler ; Yang, Qidi...
npj Precision Oncology.  8 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
9

Answering the "Doctor, can CAR-T therapy cause cancer?" que..:

Banerjee, Rahul ; Poh, Christina ; Hirayama, Alexandre V....
Blood Advances.  8 (2024)  4 - p. 895-898 , 2024
Link: https://doi.org/10.1182/..
 
?
10

Timing of anti–PD-L1 antibody initiation affects efficacy/t..:

Hirayama, Alexandre V. ; Kimble, Erik L. ; Wright, Jocelyn H....
Blood Advances.  8 (2024)  2 - p. 453-467 , 2024
Link: https://doi.org/10.1182/..
 
?
11

CLL-184 Characteristics Associated With Response to Lisocab..:

Wierda, William G. ; Maloney, David G. ; Kenderian, Saad S....
Clinical Lymphoma Myeloma and Leukemia.  24 (2024)  - p. S346 , 2024
Link: https://doi.org/10.1016/..
 
?
12

Early Prediction of Severe Icans after CD19 CAR T-Cell Ther..:

Huang, Jennifer J ; Liang, Emily C. ; Albittar, Aya...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S193-S194 , 2024
Link: https://doi.org/10.1016/..
 
?
13

Post-CAR-T Checkpoint Inhibition Can Result in Durable Resp..:

Banerjee, Rahul ; Lynch, Ryan C ; Wu, Qian Vicky...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S399-S400 , 2024
Link: https://doi.org/10.1016/..
 
?
14

Three-year follow-up analysis of axicabtagene ciloleucel in..:

Neelapu, Sattva S. ; Chavez, Julio C. ; Sehgal, Alison R....
Blood.  143 (2024)  6 - p. 496-506 , 2024
Link: https://doi.org/10.1182/..
 
?
15

Comparative Study Evaluating Hospitalizations and Critical ..:

Tiwana, Simran K. ; Krimmel, Tracy ; Huynh, Lynn...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S355 , 2024
Link: https://doi.org/10.1016/..
 
1-15